Hillhouse Capital Leads Series C Round In Chinese Medical Device Developer Brosmed
July 27, 2020 — 16:08 CST
This Data Is Locked!
This area is available only to Subscribers.
Brosmed, a Chinese vascular intervention medical device developer, has received hundreds of millions of RMB in a series C round financing led by Hillhouse Capital.... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals